263 related articles for article (PubMed ID: 23130675)
1. Toward personalized sexual medicine (part 3): testosterone combined with a Serotonin1A receptor agonist increases sexual satisfaction in women with HSDD and FSAD, and dysfunctional activation of sexual inhibitory mechanisms.
van Rooij K; Poels S; Bloemers J; Goldstein I; Gerritsen J; van Ham D; van Mameren F; Chivers M; Everaerd W; Koppeschaar H; Olivier B; Tuiten A
J Sex Med; 2013 Mar; 10(3):824-37. PubMed ID: 23130675
[TBL] [Abstract][Full Text] [Related]
2. Toward personalized sexual medicine (part 2): testosterone combined with a PDE5 inhibitor increases sexual satisfaction in women with HSDD and FSAD, and a low sensitive system for sexual cues.
Poels S; Bloemers J; van Rooij K; Goldstein I; Gerritsen J; van Ham D; van Mameren F; Chivers M; Everaerd W; Koppeschaar H; Olivier B; Tuiten A
J Sex Med; 2013 Mar; 10(3):810-23. PubMed ID: 23130748
[TBL] [Abstract][Full Text] [Related]
3. Toward personalized sexual medicine (part 1): integrating the "dual control model" into differential drug treatments for hypoactive sexual desire disorder and female sexual arousal disorder.
Bloemers J; van Rooij K; Poels S; Goldstein I; Everaerd W; Koppeschaar H; Chivers M; Gerritsen J; van Ham D; Olivier B; Tuiten A
J Sex Med; 2013 Mar; 10(3):791-809. PubMed ID: 23130782
[TBL] [Abstract][Full Text] [Related]
4. Two novel combined drug treatments for women with hypoactive sexual desire disorder.
Poels S; Bloemers J; van Rooij K; Koppeschaar H; Olivier B; Tuiten A
Pharmacol Biochem Behav; 2014 Jun; 121():71-9. PubMed ID: 24534417
[TBL] [Abstract][Full Text] [Related]
5. The influence of testosterone combined with a PDE5-inhibitor on cognitive, affective, and physiological sexual functioning in women suffering from sexual dysfunction.
van der Made F; Bloemers J; Yassem WE; Kleiverda G; Everaerd W; van Ham D; Olivier B; Koppeschaar H; Tuiten A
J Sex Med; 2009 Mar; 6(3):777-90. PubMed ID: 19207276
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of testosterone combined with a PDE5 inhibitor and testosterone combined with a serotonin (1A) receptor agonist in women with SSRI-induced sexual dysfunction. A preliminary study.
van Rooij K; Poels S; Worst P; Bloemers J; Koppeschaar H; Goldstein A; Olivier B; Tuiten A
Eur J Pharmacol; 2015 Apr; 753():246-51. PubMed ID: 25460030
[TBL] [Abstract][Full Text] [Related]
7. Response to "toward personalized sexual medicine: where is the evidence?".
Tuiten A; Bloemers J; van Rooij K; Poels S; Gerritsen J; van Ham D; de Leede L; Everaerd W
J Sex Med; 2014 Sep; 11(9):2359-63. PubMed ID: 25052951
[No Abstract] [Full Text] [Related]
8. Toward personalized sexual medicine: where is the evidence?
Leusink P; Boeke AJ; Laan E
J Sex Med; 2014 Sep; 11(9):2357-8. PubMed ID: 24964228
[No Abstract] [Full Text] [Related]
9. Childhood sexual abuse, selective attention for sexual cues and the effects of testosterone with or without vardenafil on physiological sexual arousal in women with sexual dysfunction: a pilot study.
van der Made F; Bloemers J; van Ham D; El Yassem W; Kleiverda G; Everaerd W; Olivier B; Tuiten A
J Sex Med; 2009 Feb; 6(2):429-39. PubMed ID: 19138366
[TBL] [Abstract][Full Text] [Related]
10. Safety and efficacy of sildenafil citrate for the treatment of female sexual arousal disorder: a double-blind, placebo controlled study.
Berman JR; Berman LA; Toler SM; Gill J; Haughie S;
J Urol; 2003 Dec; 170(6 Pt 1):2333-8. PubMed ID: 14634409
[TBL] [Abstract][Full Text] [Related]
11. Sexual psychophysiology and effects of sildenafil citrate in oestrogenised women with acquired genital arousal disorder and impaired orgasm: a randomised controlled trial.
Basson R; Brotto LA
BJOG; 2003 Nov; 110(11):1014-24. PubMed ID: 14592587
[TBL] [Abstract][Full Text] [Related]
12. Genotype scores predict drug efficacy in subtypes of female sexual interest/arousal disorder: A double-blind, randomized, placebo-controlled cross-over trial.
Tuiten A; Michiels F; Böcker KB; Höhle D; van Honk J; de Lange RP; van Rooij K; Kessels R; Bloemers J; Gerritsen J; Janssen P; de Leede L; Meyer JJ; Everaerd W; Frijlink HW; Koppeschaar HP; Olivier B; Pfaus JG
Womens Health (Lond); 2018; 14():1745506518788970. PubMed ID: 30016917
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and Safety of On-Demand Use of 2 Treatments Designed for Different Etiologies of Female Sexual Interest/Arousal Disorder: 3 Randomized Clinical Trials.
Tuiten A; van Rooij K; Bloemers J; Eisenegger C; van Honk J; Kessels R; Kingsberg S; Derogatis LR; de Leede L; Gerritsen J; Koppeschaar HPF; Olivier B; Everaerd W; Frijlink HW; Höhle D; de Lange RPJ; Böcker KBE; Pfaus JG
J Sex Med; 2018 Feb; 15(2):201-216. PubMed ID: 29289554
[TBL] [Abstract][Full Text] [Related]
14. Continued efficacy and safety of flibanserin in premenopausal women with Hypoactive Sexual Desire Disorder (HSDD): results from a randomized withdrawal trial.
Goldfischer ER; Breaux J; Katz M; Kaufman J; Smith WB; Kimura T; Sand M; Pyke R
J Sex Med; 2011 Nov; 8(11):3160-72. PubMed ID: 21933348
[TBL] [Abstract][Full Text] [Related]
15. Influence of sildenafil on genital engorgement in women with female sexual arousal disorder.
Leddy LS; Yang CC; Stuckey BG; Sudworth M; Haughie S; Sultana S; Maravilla KR
J Sex Med; 2012 Oct; 9(10):2693-7. PubMed ID: 22620487
[TBL] [Abstract][Full Text] [Related]
16. Testosterone patch increases sexual activity and desire in surgically menopausal women with hypoactive sexual desire disorder.
Simon J; Braunstein G; Nachtigall L; Utian W; Katz M; Miller S; Waldbaum A; Bouchard C; Derzko C; Buch A; Rodenberg C; Lucas J; Davis S
J Clin Endocrinol Metab; 2005 Sep; 90(9):5226-33. PubMed ID: 16014407
[TBL] [Abstract][Full Text] [Related]
17. Treatment of hypoactive sexual desire disorder in premenopausal women: efficacy of flibanserin in the VIOLET Study.
Derogatis LR; Komer L; Katz M; Moreau M; Kimura T; Garcia M; Wunderlich G; Pyke R;
J Sex Med; 2012 Apr; 9(4):1074-85. PubMed ID: 22248038
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of sildenafil citrate in women with sexual dysfunction associated with female sexual arousal disorder.
Basson R; McInnes R; Smith MD; Hodgson G; Koppiker N
J Womens Health Gend Based Med; 2002 May; 11(4):367-77. PubMed ID: 12150499
[TBL] [Abstract][Full Text] [Related]
19. Effect of sildenafil on subjective and physiologic parameters of the female sexual response in women with sexual arousal disorder.
Berman JR; Berman LA; Lin H; Flaherty E; Lahey N; Goldstein I; Cantey-Kiser J
J Sex Marital Ther; 2001; 27(5):411-20. PubMed ID: 11554201
[TBL] [Abstract][Full Text] [Related]
20. Induction of sexual arousal in women under conditions of institutional and ambulatory laboratory circumstances: a comparative study.
Bloemers J; Gerritsen J; Bults R; Koppeschaar H; Everaerd W; Olivier B; Tuiten A
J Sex Med; 2010 Mar; 7(3):1160-76. PubMed ID: 20136709
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
